Clinical Trial of the Efficacy and Safety of Raphamin in Combined Treatment of Community-acquired Pneumonia

ADC189 Tablets on Influenza A Virus Infection/Influenza B Virus Infection

NCT06342921 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Clinical Trial of Efficacy and Safety of ММН-407 in Acute Respiratory Viral Infection

NCT04244084 ·Status: COMPLETED ·Phase: PHASE3

A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacodynamics for the Treatment of COVID-19.

NCT04847544 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Study to Assess the Efficacy and Safety of Amizon® Max in the Treatment of Moderate Covid-19, Caused by the SARS-CoV-2 Virus

NCT04682873 ·Status: COMPLETED ·Phase: PHASE3

Pilot Clinical Trial to Explore Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

NCT05633420 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial of Efficacy and Safety of Anaferon in the Treatment of Acute Respiratory Viral Infections

NCT03707912 ·Status: COMPLETED ·Phase: PHASE4

Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia Patients

NCT04565379 ·Status: COMPLETED ·Phase: PHASE2

Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19)

NCT04487886 ·Status: COMPLETED ·Phase: PHASE2

The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients

NCT04475107 ·Status: COMPLETED ·Phase: PHASE2

Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults

NCT04250311 ·Status: SUSPENDED ·Phase: PHASE3

Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy

NCT04412252 ·Status: WITHDRAWN ·Phase: PHASE2

Oseltamivir and Baloxavir Marboxil for Prophylaxis Against Influenza Under a Hospital-based Setting

NCT06762587 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A

NCT04683406 ·Status: COMPLETED ·Phase: PHASE3

Clinical Efficacy of Nafamostat Mesylate for COVID-19 Pneumonia

NCT04418128 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Nitazoxanide Therapy for Patients With COVID-19 Pneumonia

NCT04561219 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection

NCT02532283 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19

NCT04336904 ·Status: UNKNOWN ·Phase: PHASE3

Immunomodulatory Effect of Macrolides in Naturally Occurring Influenza Virus Infections in the Community

NCT03824847 ·Status: SUSPENDED ·Phase: PHASE4

Study to Assess Efficacy and Safety of Baloxavir Marboxil In Combination With Standard-of-Care Neuraminidase Inhibitor In Hospitalized Participants With Severe Influenza

NCT03684044 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.

NCT00419263 ·Status: COMPLETED ·Phase: PHASE2

Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)

NCT04380519 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19

NCT04784897 ·Status: COMPLETED ·Phase: PHASE2

Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers

NCT04328285 ·Status: TERMINATED ·Phase: PHASE3

A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza

NCT00705406 ·Status: COMPLETED ·Phase: PHASE2

Silymarin in COVID-19 Pneumonia

NCT04394208 ·Status: UNKNOWN ·Phase: PHASE3